PRJDX
Price
$49.03
Change
+$0.04 (+0.08%)
Updated
Sep 26 closing price
Net Assets
6.32B
RPEBX
Price
$70.73
Change
+$0.36 (+0.51%)
Updated
Sep 26 closing price
Net Assets
160.61B
Interact to see
Advertisement

PRJDX vs RPEBX

Header iconPRJDX vs RPEBX Comparison
Open Charts PRJDX vs RPEBXBanner chart's image
PGIM Jennison Global Opportunities R4
Price$49.03
Change+$0.04 (+0.08%)
VolumeN/A
Net Assets6.32B
American Funds New Perspective R2E
Price$70.73
Change+$0.36 (+0.51%)
VolumeN/A
Net Assets160.61B
PRJDX vs RPEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
PRJDX vs. RPEBX commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRJDX is a Buy and RPEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RPEBX has more cash in the bank: 161B vs. PRJDX (6.32B). RPEBX pays higher dividends than PRJDX: RPEBX (0.12) vs PRJDX (0.00). PRJDX was incepted earlier than RPEBX: PRJDX (7 years) vs RPEBX (11 years). PRJDX (2.34) is less costly to investors than RPEBX (1.21). PRJDX is a more actively managed with annual turnover of: 66.00 vs. RPEBX (24.00). PRJDX has a lower initial minimum investment than RPEBX: PRJDX (0) vs RPEBX (250). RPEBX annual gain was more profitable for investors over the last year : 10.20 vs. PRJDX (1.28). RPEBX return over 5 years is better than : 37.72 vs. PRJDX (25.46).
PRJDXRPEBXPRJDX / RPEBX
Total Expense Ratio1.081.2189%
Annual Report Gross Expense Ratio2.341.21193%
Fund Existence7 years11 years-
Gain YTD8.01917.16147%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets6.32B161B4%
Annual Yield % from dividends0.000.12-
Returns for 1 year1.2810.2013%
Returns for 3 years79.9959.79134%
Returns for 5 years25.4637.7268%
Returns for 10 yearsN/A103.91-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PACS13.981.29
+10.17%
PACS Group
EBS8.910.17
+1.95%
Emergent Biosolutions
UDR37.180.47
+1.28%
UDR
LITS2.560.02
+0.79%
Lite Strategy Inc.
OGEN1.27-0.01
-0.78%
Oragenics